A BILL 
To require the Administrator of the Centers for Medicare 
& Medicaid Services to conduct a study on antipsychotic 
prescribing practices in nonnursing home settings under 
the Medicare program, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Understanding Appro-
4
priate Alzheimer’s Care Act of 2019’’. 
5
21:48 Apr 12, 2019
H1955
jbell on DSK30RV082PROD with BILLS
2 
•HR 1955 IH
SEC. 2. REQUIREMENT OF ADMINISTRATOR OF CENTERS 
1
FOR MEDICARE & MEDICAID SERVICES TO 
2
CONDUCT STUDY ON ANTIPSYCHOTIC PRE-
3
SCRIBING PRACTICES IN NONNURSING HOME 
4
SETTINGS UNDER MEDICARE PROGRAM. 
5
Not later than the date that is 18 months after the 
6
date of the enactment of this Act, the Administrator of 
7
the Centers for Medicare & Medicaid Services shall, in co-
8
ordination with the heads of other entities within the De-
9
partment of Health and Human Services (as determined 
10
appropriate by the Secretary of Health and Human Serv-
11
ices) and the Comptroller General of the United States— 
12
(1) conduct a study on antipsychotic prescribing 
13
practices in nonnursing home settings under the 
14
Medicare program under title XVIII of the Social 
15
Security Act (42 U.S.C. 1395 et seq.) that as-
16
sesses— 
17
(A) whether antipsychotic prescribing prac-
18
tices in such nonnursing home settings are ap-
19
propriate or inappropriate; 
20
(B) whether individuals who have been 
21
prescribed antipsychotic medications in such 
22
nonnursing home settings have had improved 
23
health outcomes, taking into account the dura-
24
tion of any such prescription; 
25
(C) whether physicians— 
26
21:48 Apr 12, 2019
H1955
jbell on DSK30RV082PROD with BILLS
3 
•HR 1955 IH
(i) are aware of the health risks of 
1
antipsychotic medications for individuals 
2
with Alzheimer’s disease; and 
3
(ii) 
attempt 
to 
use 
nonpharma-
4
cological interventions before prescribing 
5
such medications for such individuals; and 
6
(D) whether individuals who have been 
7
prescribed antipsychotic medications in such 
8
nonnursing home settings, and the families of 
9
such individuals, are aware of the health risks 
10
of such medications; and 
11
(2) submit to Congress and the Secretary of 
12
Health and Human Services, and make publicly 
13
available, a report on the findings of such study, in-
14
cluding recommendations for how inappropriate 
15
antipsychotic prescribing practices in such non-
16
nursing home settings may be reduced. 
17
Æ 
21:48 Apr 12, 2019
H1955
jbell on DSK30RV082PROD with BILLS
